Pembrolizumab as Neoadjuvant Treatment in HCC

NCT03337841 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Pembrolizumab

Sponsor

Kindai University

Collaborators

[object Object]